Incyte Corp
NASDAQ:INCY
Incyte Corp
NASDAQ:INCY
Price:
57.79 USD
0.86%
Market Closed
Updated:
Jun 1, 2024
Incyte Corp
PP&E Gross
|
Incyte Corp
PP&E Gross Peer Comparison
Comparables:
ABBV
GILD
AMGN
VRTX
REGN
Competitive PP&E Gross Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | PP&E Gross | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Incyte Corp
NASDAQ:INCY
|
PP&E Gross
$745.5m
|
CAGR 3-Years
6%
|
CAGR 5-Years
17%
|
CAGR 10-Years
34%
|
|
|
Abbvie Inc
NYSE:ABBV
|
PP&E Gross
$5B
|
CAGR 3-Years
-1%
|
CAGR 5-Years
9%
|
CAGR 10-Years
8%
|
|
|
Gilead Sciences Inc
NASDAQ:GILD
|
PP&E Gross
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Amgen Inc
NASDAQ:AMGN
|
PP&E Gross
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
PP&E Gross
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
PP&E Gross
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Incyte Corp's PP&E Gross?
PP&E Gross
745.5m
USD
745.5m
USD
Based on the financial report for Mar 31, 2024, Incyte Corp's PP&E Gross amounts to 745.5m USD.
What is Incyte Corp's PP&E Gross growth rate?
PP&E Gross CAGR 10Y
34%
34%
Over the last year, the PP&E Gross growth was -3%. The average annual PP&E Gross growth rates for Incyte Corp have been 6% over the past three years , 17% over the past five years , and 34% over the past ten years .
You don't have any saved screeners yet
